spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  Affymax 

 HSMN NewsFeed - 17 Dec 2015
Aimmune Therapeutics Appoints Jeffrey H. Knapp as Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2015
Alder BioPharmaceuticals Appoints Paul B. Cleveland to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 Aug 2014
Dermira Completes $51 Million Financing and Expands Management Team and Board of Directors
Biopharmaceuticals Dermatology Venture Capital Personnel
 HSMN NewsFeed - 20 May 2014
Spero Therapeutics Appoints Thomas Parr, Ph.D. as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Jan 2014
Seattle Genetics Appoints John A. Orwin to Board of Directors
Biopharmaceuticals Drug Delivery Oncology Personnel
 HSMN NewsFeed - 8 Oct 2013
ZS Pharma Appoints Cynthia Smith as Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Aug 2013
bioTheranostics Appoints Three Key Executives
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 7 Nov 2012
John A. Orwin Joins Array BioPharma Board Of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 9 Jul 2012
Affymax Promotes Michael Holfinger, Ph.D., to Vice President, Manufacturing and CMC Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Feb 2011
Affymax Announces Appointment of Herb Cross as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Nov 2010
Affymax Names Herb Cross as Chief Accounting Officer and Vice President of Finance
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Apr 2010
Affymax Names John A. Orwin President and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Mar 2010
Portola Pharmaceuticals Announces Senior Management and Board Changes
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Mar 2010
Afraxis Appoints Chief Scientific Officer and Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Feb 2010
Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Biopharmaceuticals Cardiology Personnel
 HSMN NewsFeed - 30 Oct 2008
Alnara Pharmaceuticals, Inc. Secures $20 Million in Series A Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Jun 2008
Affymax(R) Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2008
Kythera Biopharmaceuticals Announces $40M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Feb 2008
Calistoga Pharmaceuticals Announces Appointment of R. Lee Douglas, 22-Year Biotechnology/Pharmaceutical Industry Veteran, to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Kosan Appoints Helen S. Kim as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2007
Affymax(R) Announces Retirement Plans of Robert B. Naso, Ph.D. Executive Vice President, Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Oct 2007
Phenomix Hires John Crawford as Chief Financial Officer and Appoints Arlene Morris to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Oct 2007
Anaptys Biosciences Appoints R. Scott Greer to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2007
Novacea Appoints John P. Walker as CEO
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 14 Aug 2007
Affymax(R) Names Robert F. Venteicher, Ph.D., Vice President, Technical Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 Jul 2007
Affymax Announces Executive Management Promotions
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2007
Affymax(R) Announces Phase 3 Development Plan for Hematide(TM)
Biopharmaceuticals
 HSMN NewsFeed - 13 Jun 2007
Affymax(R) Announces Resignation of Elizabeth A. Czerepak From its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Apr 2007
Affymax(R) Announces Phase 2 Clinical Trial Results of Once-Per-Month Hematide(TM) for the Treatment of Anemia in Patients with Early- and End-Stage Chronic Kidney Disease
Biopharmacetuicals
 HSMN NewsFeed - 12 Apr 2007
Affymax(R) Announces Results From Phase 2 Clinical Trial of Hematide(TM) for the Treatment of Anemia in Dialysis Patients
Biopharmaceuticals
 HSMN NewsFeed - 8 Jan 2007
Cerimon Pharmaceuticals Names Daniel Levitt, M.D., Ph.D. Executive Vice President of Research and Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Dec 2006
Receptor BioLogix Names Four New Senior Executives
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2006
Affymax Appoints Grace U. Shin as Vice President of Legal Affairs and Corporate Counsel
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2006
Affymax Appoints Daniel K. Spiegelman to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Jun 2006
Affymax Appoints Kay Slocum as Senior Vice President of Human Resources
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 25

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 25 additional stories matching:
Affymax
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.